Drug intelligence / Profile preview

carisoprodol + aspirin + caffeine

Development stage
Unknown
Lead developer
Wallace Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

**Carisoprodol + aspirin + caffeine** is a combination drug consisting of three active ingredients: carisoprodol, a centrally acting skeletal muscle relaxant; aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and anti-inflammatory effects; and caffeine, a central nervous system stimulant sometimes included in analgesic combinations to enhance pain relief. Carisoprodol acts on the central nervous system to relieve muscle spasms primarily by blocking interneuronal activity in the spinal cord and reticular formation. Aspirin relieves pain and inflammation by inhibiting prostaglandin synthesis through irreversible inhibition of cyclooxygenase enzymes. Caffeine is thought to exert adjuvant analgesic effects, likely through adenosine receptor antagonism and vasoconstrictive properties, though its precise analgesic enhancement mechanism is not fully established. This combination is typically used for short-term relief of discomfort associated with acute, painful musculoskeletal conditions and is available by prescription only. The product is not intended as a substitute for rest, physical therapy, and other components of musculoskeletal management.

02

Targets

ADORA2A (Adenosine A₂A Receptor)GABRR (GABA-A receptor subunit rho)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADORA1 (Adenosine receptor A1 subtype)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on carisoprodol + aspirin + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carisoprodol + aspirin + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call